Wanbangde Pharmaceutical Holding Group Co Ltd (002082) — Cash Flow Reinvestment Rate
Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Cash Flow Reinvestment Rate of 2.60x as of June 2025, reinvesting CN¥159.76 Million (capex CN¥153.03 Million plus investments CN¥6.73 Million) from operating cash flow of CN¥61.33 Million. See Wanbangde Pharmaceutical Holding Group C free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Wanbangde Pharmaceutical Holding Group Co Ltd Cash Flow Reinvestment Rate (2003–2025)
Historical reinvestment intensity for Wanbangde Pharmaceutical Holding Group Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see 002082 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)
Year-by-year capital reinvestment analysis for Wanbangde Pharmaceutical Holding Group Co Ltd. See Wanbangde Pharmaceutical Holding Group C free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.49x | CN¥297.81 Million | CN¥603.98 Million | CN¥289.65 Million | ▼ -69.9% |
| 2024 | 1.64x | CN¥197.22 Million | CN¥120.22 Million | CN¥88.43 Million | ▼ -97.2% |
| 2021 | 57.80x | CN¥1.28 Billion | CN¥22.09 Million | CN¥277.06 Million | ▲ +1357.0% |
| 2020 | 3.97x | CN¥599.04 Million | CN¥151.01 Million | CN¥559.24 Million | ▲ +142.1% |
| 2018 | 1.64x | CN¥221.87 Million | CN¥135.40 Million | CN¥199.64 Million | ▲ +4926.7% |
| 2016 | 0.03x | CN¥10.13 Million | CN¥310.71 Million | CN¥9.03 Million | ▼ -98.2% |
| 2015 | 1.82x | CN¥30.47 Million | CN¥16.76 Million | CN¥30.47 Million | ▲ +467.9% |
| 2014 | 0.32x | CN¥44.91 Million | CN¥140.31 Million | CN¥44.91 Million | ▲ +502.5% |
| 2013 | 0.05x | CN¥12.45 Million | CN¥234.35 Million | CN¥12.45 Million | ▼ -73.7% |
| 2012 | 0.20x | CN¥40.92 Million | CN¥202.73 Million | CN¥40.92 Million | ▼ -25.6% |
| 2010 | 0.27x | CN¥44.02 Million | CN¥162.26 Million | CN¥44.02 Million | ▼ -69.2% |
| 2009 | 0.88x | CN¥60.02 Million | CN¥68.13 Million | CN¥60.02 Million | ▲ +51.7% |
| 2008 | 0.58x | CN¥146.92 Million | CN¥253.06 Million | CN¥146.92 Million | ▼ -93.4% |
| 2007 | 8.81x | CN¥109.68 Million | CN¥12.45 Million | CN¥109.68 Million | ▼ -67.0% |
| 2006 | 26.70x | CN¥93.47 Million | CN¥3.50 Million | CN¥93.47 Million | ▲ +241.2% |
| 2005 | 7.83x | CN¥87.86 Million | CN¥11.23 Million | CN¥87.86 Million | ▲ +160.2% |
| 2004 | 3.01x | CN¥98.30 Million | CN¥32.69 Million | CN¥98.30 Million | ▲ +193.5% |
| 2003 | 1.02x | CN¥37.92 Million | CN¥37.01 Million | CN¥37.92 Million | — |